Safety and immunogenicity of the heterologous prime-boost ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN (R) FILO in healthy UK adults
Viral vectored vaccines using chimpanzee adenoviruses and Modified Vaccinia Ankara (MVA) vectors have demonstrated efficacy against Ebolavirus challenge in non-human primates. This Phase 1 trial was designed to assess the safety and immunogenicity of 2 novel Ebolavirus vaccines in healthy UK adults:...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2015
|